Design Therapeutics
DSGN
DSGN
93 hedge funds and large institutions have $124M invested in Design Therapeutics in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 37 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3.21% less ownership
Funds ownership: 57.61% → 54.39% (-3.2%)
43% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 37
78% less call options, than puts
Call options by funds: $4K | Put options by funds: $18K
Holders
93
Holding in Top 10
1
Calls
$4K
Puts
$18K
Top Buyers
| 1 | +$2.39M | |
| 2 | +$1.16M | |
| 3 | +$897K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$864K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$653K |
Top Sellers
| 1 | -$3.86M | |
| 2 | -$2.45M | |
| 3 | -$2.09M | |
| 4 |
Renaissance Technologies
New York
|
-$787K |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$742K |